HIGHLIGHTS
- who: Weike Liu and colleagues from the Department of Pediatrics, Chengyang District People`s Hospital of Qingdao, Qingdao, Shandong, China have published the Article: Exosomal miR-221-3p Derived from Bone Marrow Mesenchymal Stem Cells Alleviates Asthma Progression by Targeting FGF2 and Inhibiting the ERK1/2 Signaling Pathway, in the Journal: Evidence-Based Complementary and Alternative Medicine of 10/08/2022
- what: The authors investigated the effects and regulatory mechanism of exosomal miR-221-3p derived from BMSCs on TGF-u03b21-induced proliferation, migration, and ECM deposition in ASMCs, and then verified its effect on . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.